First RSV vaccine trial for infants offers significant results
The phase 3 MELODY study reveals that nirsevimab vaccine reduces lower respiratory tract infections
Read More
Author: John Pinching
Previously untreatable lung cancer patients offered new therapy
NICE document recommends Amgen’s Lumykras (sotorasib) to treat non-small-cell lung cancer
Read More
Clinical jobs increase as R&D and lab roles experience record growth
The post-Brexit landscape has witnessed an exponential boom in life science careers
Read More
Novartis’ Kesimpta trial provides positive results for MS patients
MS patients given boost by results of study into Kesimpta – a self-administered treatment with potential to improve lives
Read More
Brain Training: BioMed X Institute collaborates with Boehringer Ingelheim
Sensor development project marks the fifth joint research effort between BioMed X with Boehringer Ingelheim
Read More- Tozorakimab shows significant benefit in two major COPD trials
- Daratumumab becomes first oncology injectable approved for patient administration
- Laigo Bio completes final close of €17m seed financing round
- Axplora announces expansion as newest part of $60m API investment programme
- DNA Script signs SYNTAX distribution agreements with Gencell, BMS and Biostream
